Practical tips when taking Mounjaro, based on clinical evidence

Injection timing, site rotation and what the pen actually needs from you

The SmPC licences Mounjaro as a once-weekly injection on any day of your choosing, but your prescriber will encourage you to pick a day and stick to it. Consistency matters partly for habit and partly because the pen delivers four weekly doses — and the KwikPen device itself requires a small amount of preparation each time. Before injecting, check the liquid looks clear and colourless through the viewing window; if it appears cloudy or has particles, contact your prescriber rather than using it.

Injection sites matter more than many people expect. Rotating between the abdomen, thigh and upper arm reduces the chance of a lump or soreness at any single spot, and absorption can vary slightly by site, so keeping a mental or written note of where you injected last week helps. The pen arrives refrigerated, when your DPD box turns up, plain and unbranded, you will want to transfer it to the fridge door promptly. Room-temperature tolerance is real but time-limited; the exact window is in the Patient Information Leaflet inside the box, and that leaflet is the authority, not a general estimate from online sources.

If you miss a dose and the next scheduled injection is five or more days away, you can inject as soon as you remember. If it is fewer than five days to your next dose, skip the missed one and continue as planned. Missed-dose decisions should always be confirmed with your prescriber or the leaflet, never adjust frequency on your own initiative. For further background on what taking Mounjaro involves week to week, the detail is covered separately.

Eating and drinking on Mounjaro: what the evidence actually supports

Mounjaro slows gastric emptying, which means food sits in your stomach longer. That is part of the mechanism behind reduced appetite, but it also means large, high-fat meals can feel extremely uncomfortable and are more likely to trigger nausea or reflux. Trial participants who reported the fewest side effects tended to eat smaller portions, reduce ultra-processed foods gradually rather than abruptly, and prioritise protein at each meal to help preserve lean mass during weight loss.

Protein adequacy is a practical concern that does not always appear prominently on information pages: when calorie intake falls significantly, the body can draw on muscle as well as fat. Aiming for an adequate protein intake (broadly 1.2–1.6 g per kilogram of body weight per day, though your prescriber or a dietitian can advise a personal target) helps maintain strength and metabolic rate. Fibre similarly deserves attention; constipation is a recognised side effect and a diet that has dropped in calories but retained vegetables, wholegrains and legumes manages this better than a low-fibre approach.

Hydration is underestimated. GI side effects, especially diarrhoea and vomiting, can cause significant fluid loss; sipping water steadily through the day rather than in large gulps is easier on a stomach that empties slowly. Alcohol warrants a mention: it adds calories, worsens reflux, and some people find their tolerance shifts on treatment. No hard prohibition exists in the SmPC, but moderation is sensible. You can read more about how tirzepatide works as a medicine to understand why these dietary adjustments follow logically from its mechanism.

Side effects worth knowing about and when to get medical help

The gastrointestinal side-effect profile (nausea, vomiting, diarrhoea, constipation, indigestion, burping) is well documented in SURMOUNT-1, where these effects were most common during dose-escalation weeks and generally settled with time. Knowing that nausea is likeliest in the two to three days after a dose increase, and that it is not necessarily a sign something is wrong, helps patients stay with treatment rather than stopping unnecessarily. If you want practical guidance on making each injection as comfortable as possible, our tips for taking Mounjaro cover injection-day habits that many people find genuinely useful.

Some symptoms require prompt medical attention, and the NHS tirzepatide guidance sets these out clearly. Severe, persistent abdominal pain that radiates to the back (with or without vomiting) should be assessed urgently because it can indicate acute pancreatitis, a known but uncommon risk with GLP-1 medicines highlighted in a 2026 MHRA Drug Safety Update. Symptoms of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing) also need emergency care.

If you suspect a side effect, you can report it directly to the MHRA via the Yellow Card scheme, this applies even if you are unsure whether the medicine is the cause. Keep your prescriber informed too, particularly about anything that does not settle within two weeks or that gets worse at a dose you have been on for several weeks. For questions specific to your circumstances, our support team is available seven days a week.

Supporting your treatment with activity, and knowing what to discuss with your prescriber

Physical activity is listed alongside reduced-calorie diet in Mounjaro's UK licence, not as an optional add-on but as part of the licensed indication. The clinical rationale is preserving and building lean mass while body weight falls, and evidence consistently shows that resistance-based exercise (bodyweight, weights, resistance bands) is particularly valuable in this context. Walking is accessible, low-impact and can be built up gradually without requiring gym membership or significant joint loading.

Starting or significantly increasing activity at the same time as a dose escalation can, on rare occasions, compound the risk of feeling lightheaded or fatigued. Pacing the changes (increasing movement when the current dose feels settled) is generally more manageable. Your prescriber is the right person to talk through what is appropriate for your starting fitness level, any musculoskeletal conditions, and your overall progress.

Conversations with your prescriber should also cover any other medicines you take regularly. Oral contraceptives, in particular, may be affected by slowed gastric emptying in the early weeks of Mounjaro treatment and after each dose increase; UK guidance recommends adding a barrier method during those windows. Women taking oral HRT may also wish to discuss whether a transdermal form is more appropriate while on tirzepatide. These are not dramatic cautions, they are practical adjustments that a clinical review surfaces, which is why every Mounjaro treatment at nume begins with a thorough prescriber assessment rather than a questionnaire processed by software.

Cost context is a fair consideration for anyone planning ongoing treatment. Privately, Mounjaro pricing varies by dose and provider; what drives Mounjaro's cost in the UK and what a legitimate price should include are covered in detail. If you are based in Hong Kong and exploring your options, our Mounjaro HK page explains what is available and how to get started. If you would like to explore whether treatment is clinically right for you, check your eligibility with our prescribers, the consultation is free.